OS Therapies OSTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$10.4M-168% | -$13.46M-350% | -$6.88M-139% | -$4.54M-191% | -$3.88M-166% | ||
| $124.94K+17,877% | $124.94K+8,888% | $124.94K— | $112.51K+16,089% | $6950.0% | ||
| $1.44M+52.5% | $1.6M+2,292% | $814.93K+1,115% | $905.18K+1,250% | $941.28K+1,303% | ||
| $68.97K+106% | —— | —— | —— | -$1.12M-294% | ||
| $3.88M+2,019% | $1.02M+354% | —— | —— | -$202.28K— | ||
| -$63.08K— | -$340.13K— | -$348.75K— | —— | —— | ||
| -$6.37K— | —— | —— | —— | —— | ||
| -$4.56M-32.6% | -$3.73M-57.1% | -$4.71M-39.0% | -$2.36M-168% | -$3.44M-436% | ||
| —— | —— | —— | $316.42K— | $150K— | ||
| $7.35M+462% | $8.8M+911% | $3.76M+210% | $2.5M+530% | $1.31M+262% | ||
| —— | —— | —— | -$292.79K— | -$173.64K— | ||
| $1.84M— | —— | —— | —— | —— | ||
| —— | —— | $1.05M-76.5% | $400K— | $568.24K— | ||
| —— | —— | —— | —— | $0-100% | ||
| $5.21M+395% | $2.12M-64.9% | $3.78M-26.6% | $2.48M+184% | $1.05M+49.8% | ||
| $647.72K+125% | -$1.61M-144% | -$925.39K-152% | -$168.99K— | -$2.56M-4,284% | ||
| $124.24K— | —— | —— | —— | $0— | ||
| $1.44M+52.5% | $1.6M+498% | $814.93K— | $905.18K— | $941.28K— | ||
| $68.97K+106% | —— | —— | —— | -$1.12M-294% | ||
| —— | —— | —— | —— | $568.24K— | ||
| -$6.37K— | —— | —— | —— | —— | ||
| -$37.08K+61.8% | —— | —— | -$270— | -$96.99K— | ||
| -$63.08K— | -$340.13K— | -$348.75K— | —— | —— | ||
| $289.2K-16.6% | $0-100% | $239.25K+3,728% | $10K+60.0% | $346.59K+5,445% | ||
| -$10.4M-168% | -$13.46M-350% | -$6.88M-139% | -$4.54M-191% | -$3.88M-160% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $23.64K— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $1.05M-30.4% | ||
| —— | $33.55K-39.8% | $33.55K-39.8% | $33.55K-39.8% | $33.55K-39.8% | ||
| —— | —— | —— | —— | $722.22K— | ||
| —— | $27.5K— | $27.5K— | $27.5K— | $27.5K— | ||
| -$0.27-50.0% | -$0.41+35.9% | -$0.21-16.7% | -$0.19+26.9% | -$0.18+28.0% | ||
| -$0.27-50.0% | -$0.41+35.9% | -$0.21-16.7% | -$0.19+26.9% | -$0.18+28.0% | ||
| 50%0.0% | 50%0.0% | —— | —— | 50%0.0% | ||
| —— | —— | —— | -$302.04K— | -$1.12M— | ||
| $2.82M-23.7% | $3.19M+52.3% | $3.12M+155% | $2.34M+510% | $3.69M+1,275% | ||
| —— | $625K— | $625K— | $625K— | $625K— | ||
| $75.34K— | —— | —— | —— | —— | ||
| $45-31.8% | $54— | $65— | $64+6,300% | $66— | ||
| $22.38M0.0% | —— | —— | —— | $22.38M+300% | ||
| -$228.89K-120% | -$1.47M-5,837% | $65+100% | $302.11K+139% | $1.12M+235% | ||
| -$10.17M-103% | -$11.99M-304% | -$6.88M-182% | -$4.84M-521% | -$5M-693% | ||
| —— | 10%— | —— | —— | —— | ||
| $0— | —— | —— | —— | $0-100% | ||
| $266.32K+300% | $66.58K— | $66.58K— | $66.58K— | $66.58K— | ||
| $3.38M+2,447% | $132.54K— | $132.54K— | $132.54K— | $132.54K— | ||
| $15.13K+300% | $3.78K— | $3.78K— | $3.78K— | $3.78K— | ||
| $2.43K-22.8% | $4.88K+1,015% | $0-100% | $2.36K+440% | $3.15K+620% | ||
| 112%— | 112%+6.0% | —— | —— | —— | ||
| 3.8%— | 3.6%-0.5% | —— | —— | —— | ||
| —— | —— | —— | —— | $1.45M— | ||
| $125— | —— | —— | —— | —— | ||
| 38.7M+82.0% | 29.3M+321% | 32M+101% | 25.1M+319% | 21.2M+255% | ||
| —— | -$3.73M— | -$4.71M— | -$2.68M— | -$3.59M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does OS Therapies generate?
- OS Therapies (OSTX) generated -$15.4M in operating cash flow over the trailing twelve months.
- What is OS Therapies's free cash flow?
- OS Therapies's free cash flow was -$14.7M over the trailing twelve months.
- Where does OS Therapies's cash flow data come from?
- Every line is extracted from OS Therapies's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.